<?xml version='1.0' encoding='utf-8'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>EMA Medicine Updates</title>
    <link>https://www.ema.europa.eu/en/medicines</link>
    <description>Monitored updates for specific medicines from the European Medicines Agency.</description>
    <lastBuildDate>Mon, 22 Dec 2025 07:47:27 -0000</lastBuildDate>
    <atom:link href="ema_updates.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/qtern</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/qtern</guid>
      <description>Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised</description>
      <pubDate>Thu, 18 Dec 2025 12:02:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/xigduo</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/xigduo</guid>
      <description>Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised</description>
      <pubDate>Thu, 18 Dec 2025 12:01:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ebymect</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/ebymect</guid>
      <description>Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised</description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Summary of opinion: Mounjaro, 11/12/2025 Positive</title>
      <link>https://www.ema.europa.eu/en/medicines/human/variation/mounjaro</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/variation/mounjaro</guid>
      <description>Summary of opinion: Mounjaro, 11/12/2025 Positive</description>
      <pubDate>Fri, 12 Dec 2025 13:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Xelevia : EPAR - Procedural steps taken and scientific information after authorisation (archive)</title>
      <link>https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0762-steps-after_en_0.pdf</link>
      <guid>https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0762-steps-after_en_0.pdf</guid>
      <description>Xelevia : EPAR - Procedural steps taken and scientific information after authorisation (archive)</description>
      <pubDate>Mon, 01 Dec 2025 16:33:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/velmetia</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/velmetia</guid>
      <description>Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised</description>
      <pubDate>Mon, 01 Dec 2025 15:44:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/efficib</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/efficib</guid>
      <description>Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised</description>
      <pubDate>Mon, 01 Dec 2025 13:10:00 -0000</pubDate>
    </item>
    <item>
      <title>Tesavel : EPAR - Procedural steps taken and scientific information after authorisation (archive)</title>
      <link>https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0910-steps_after_en_0.pdf</link>
      <guid>https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0910-steps_after_en_0.pdf</guid>
      <description>Tesavel : EPAR - Procedural steps taken and scientific information after authorisation (archive)</description>
      <pubDate>Mon, 01 Dec 2025 11:08:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/steglujan</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/steglujan</guid>
      <description>Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised</description>
      <pubDate>Fri, 21 Nov 2025 14:58:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ristfor</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/ristfor</guid>
      <description>Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised</description>
      <pubDate>Mon, 17 Nov 2025 16:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information</title>
      <link>https://www.ema.europa.eu/system/files/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf</link>
      <guid>https://www.ema.europa.eu/system/files/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf</guid>
      <description>Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information</description>
      <pubDate>Thu, 13 Nov 2025 14:04:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/janumet</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/janumet</guid>
      <description>Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised</description>
      <pubDate>Thu, 13 Nov 2025 08:20:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 3, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-sun</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-sun</guid>
      <description>Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 3, Status: Authorised</description>
      <pubDate>Mon, 10 Nov 2025 15:50:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 35, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/januvia</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/januvia</guid>
      <description>Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 35, Status: Authorised</description>
      <pubDate>Fri, 31 Oct 2025 10:13:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ristaben</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/ristaben</guid>
      <description>Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised</description>
      <pubDate>Thu, 30 Oct 2025 15:36:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan</guid>
      <description>Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised</description>
      <pubDate>Tue, 30 Sep 2025 13:27:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 12, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy</guid>
      <description>Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 12, Status: Authorised</description>
      <pubDate>Tue, 30 Sep 2025 11:49:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 15, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/rybelsus</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/rybelsus</guid>
      <description>Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 15, Status: Authorised</description>
      <pubDate>Tue, 30 Sep 2025 11:39:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 18, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic</guid>
      <description>Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 18, Status: Authorised</description>
      <pubDate>Tue, 30 Sep 2025 11:20:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/kyinsu</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/kyinsu</guid>
      <description>Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion</description>
      <pubDate>Fri, 19 Sep 2025 10:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 19, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/saxenda</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/saxenda</guid>
      <description>Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 19, Status: Authorised</description>
      <pubDate>Thu, 31 Jul 2025 15:09:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/apremilast-accord</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/apremilast-accord</guid>
      <description>Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised</description>
      <pubDate>Fri, 18 Jul 2025 14:47:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Otezla, apremilast, Date of authorisation: 15/01/2015, Revision: 24, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/otezla</link>
      <guid>https://www.ema.europa.eu/en/medicines/human/EPAR/otezla</guid>
      <description>Human medicines European public assessment report (EPAR): Otezla, apremilast, Date of authorisation: 15/01/2015, Revision: 24, Status: Authorised</description>
      <pubDate>Wed, 16 Jul 2025 08:53:00 -0000</pubDate>
    </item>
  </channel>
</rss>